Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Bse Healthcare
Bse Healthcare Performance
Low
₹47,691.28
High
₹48,559.56
52 Week Range
Low
₹40,239.45
High
₹52,293.87
| Previous Close | ₹47,764.66 |
|---|---|
| Day's Range | ₹47,691.28 - ₹48,559.56 |
| Open | ₹48,242.52 |
| 52 Week Range | ₹40,239.45 - ₹52,293.87 |
| Volume | 72,95,276 |
Bse Healthcare Companies
| Company Name | LTP (₹) | Change (₹) | Sector |
|---|---|---|---|
| Ambalal Sarabhai Enterprises Ltd. | 39.50 |  1.37 (3.59%) |
Healthcare |
| Cipla Ltd. | 1331.00 | 6.00 (0.45%) |
Healthcare |
| Dr. Reddy's Laboratories Ltd. | 1242.00 | 10.15 (0.82%) |
Healthcare |
| Procter & Gamble Health Ltd. | 5154.00 |  -51.85 (-1.00%) |
Healthcare |
| Lupin Ltd. | 1953.75 | -2.05 (-0.10%) |
Healthcare |
| Morepen Laboratories Ltd. | 122.50 | -1.10 (-0.89%) |
Healthcare |
| Torrent Pharmaceuticals Ltd. | 4545.90 | -14.10 (-0.31%) |
Healthcare |
| Abbott India Ltd. | 25794.25 | -360.60 (-1.38%) |
Healthcare |
| Glaxosmithkline Pharmaceuticals Ltd. | 2500.00 | -65.20 (-2.54%) |
Healthcare |
| Evonile Pharma Ltd. | 1925.00 | 24.35 (1.28%) |
Trading |
| Index Name | Market Value | 52W High | 52W Low |
|---|---|---|---|
| Nifty 50 | 22888.95 | 26373.20 | 22179.90 |
| Nifty IT | 31516.3 | 40301.40 | 25699.10 |
| Nifty Next 50 | 68695.85 | 75000.40 | 59896.10 |
| NIFTY50 USD Index | 8357.6 | 10443.40 | 7839.85 |
| Nifty Bank | 55488.1 | 61764.85 | 49954.85 |
| NIFTY Midcap 100 | 58487.95 | 64450.90 | 52032.85 |
| Nifty 500 | 22041.6 | 24144.20 | 20385.65 |
| Nifty Midcap 50 | 16767.85 | 18500.95 | 14804.55 |
| Nifty 100 | 23895.45 | 26975.15 | 22720.45 |
| Nifty FMCG | 43975.5 | 57445.20 | 43442.30 |
Latest News
Krishna Institute of Medical Sciences submits analyst meet intimation
Zydus Lifesciences submits board meeting intimation
Jupiter Life Line Hospitals informs about updates
Indraprastha Medical Corporation informs about board meeting
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indraprastha Medical Corporation has informed that a meeting of the Board of Directors of the Company will be held on Thursday, 29th October, 2026, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2026.
The above information is a part of company’s filings submitted to BSE.
Supriya Lifescience informs about further update on judicial proceedings
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation to the earlier intimations made by the Company in relation to Judicial Proceedings, Supriya Lifescience has informed that the matter has been admitted by the Hon’ble Supreme Court and is listed for hearing. Further, the Hon’ble Supreme Court has, in the interim, directed that no coercive action shall be taken against the Directors/officers/officials of the petitioner, subject to the terms and conditions of the order passed by the Hon’ble Court. The matter is presently pending before the Hon’ble Court and is sub judice. The Company shall continue to monitor the proceedings and shall keep the Stock Exchanges and its shareholders informed of any material developments in the matter as and when received from the Hon’ble Court or otherwise in accordance with applicable laws and regulations.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The previous close of index is ₹ as of .
The total volume of index is as of .
The percentage change in value of index is % as of .
The absolute increase in index value since the previous trading day is ₹ as of .
A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
